Filter

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 7 of 7 items for :

Clear All
José V Lima Jr Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil
Fleury Group, São Paulo, SP, Brazil

Search for other papers by José V Lima Jr in
Google Scholar
PubMed Close
,
Nilza M Scalissi Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil

Search for other papers by Nilza M Scalissi in
Google Scholar
PubMed Close
,
Kelly C de Oliveira Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Search for other papers by Kelly C de Oliveira in
Google Scholar
PubMed Close
,
Susan C Lindsey Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Search for other papers by Susan C Lindsey in
Google Scholar
PubMed Close
,
Caroline Olivati Fleury Group, São Paulo, SP, Brazil

Search for other papers by Caroline Olivati in
Google Scholar
PubMed Close
,
Elisa Napolitano Ferreira Fleury Group, São Paulo, SP, Brazil

Search for other papers by Elisa Napolitano Ferreira in
Google Scholar
PubMed Close
, and
Claudio E Kater Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Search for other papers by Claudio E Kater in
Google Scholar
PubMed Close

). Cluster 2 has signature activation of MAP kinase signaling pathways. The following genes stand out: NF1, RET, HRAS, and TMEM127 (9–11). Cluster 3 (identified by The Cancer Genome Atlas) has WnT pathways based on a transcriptional signature, which

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-22-0091
Volume/Issue:
Volume 3: Issue 1
Open access
Vineeth Sukrithan Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Vineeth Sukrithan in
Google Scholar
PubMed Close
,
Prachi Jain Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Prachi Jain in
Google Scholar
PubMed Close
,
Manisha H Shah Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Manisha H Shah in
Google Scholar
PubMed Close
, and
Bhavana Konda Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Bhavana Konda in
Google Scholar
PubMed Close

agents or in combination with other therapies. Molecular targets in thyroid cancer Differentiated thyroid cancer Alterations in BRAF, RET, RAS, PIK3CA, and PTEN activate the MAPK and phosphoinositide 3-kinase (PI3K) pathways leading to the

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0062
Volume/Issue:
Volume 3: Issue 1
Open access
Christie G Turin Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA

Search for other papers by Christie G Turin in
Google Scholar
PubMed Close
,
Molly M Crenshaw Department of Pediatrics, Combined Pediatrics-Medical Genetics Residency Program, University of Colorado, Aurora, Colorado, USA

Search for other papers by Molly M Crenshaw in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA
Division of Biomedical Informatics and Personalized Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

/PGL Adrenal PCC HNPGL Extra-adrenal PGL Risk of multifocal primary PCC/PGL Risk of metastatic disease VHL Autosomal dominant 19% 60% for type 2 +++ + + +++ <5% RET Autosomal dominant 50% +++ + + +++ <5

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0044
Volume/Issue:
Volume 2: Issue 1
Open access
Sofia Maria Lider Burciulescu CI Parhon National Institute of Endocrinology, Bucharest, Romania

Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed Close
,
Caren Randon Department of Thoracic and Vascular Surgery, Ghent University Hospital & Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Caren Randon in
Google Scholar
PubMed Close
,
Frederic Duprez Department of Radiotherapy-Oncology, Ghent University Hospital, Ghent Belgium & Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Frederic Duprez in
Google Scholar
PubMed Close
,
Wouter Huvenne Department of Head and Neck Surgery, Ghent University Hospital & Department of Head & Skin, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Wouter Huvenne in
Google Scholar
PubMed Close
,
David Creytens Department of Pathology, Ghent University Hospital, Ghent University & Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by David Creytens in
Google Scholar
PubMed Close
,
Kathleen B M Claes Center for Medical Genetics, Ghent University Hospital & Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Kathleen B M Claes in
Google Scholar
PubMed Close
,
Robin de Putter Center for Medical Genetics, Ghent University Hospital & Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Robin de Putter in
Google Scholar
PubMed Close
,
Guy T’Sjoen Department of Endocrinology, Ghent University Hospital & Department of Internal Medicine & Pediatrics, Faculty of Medicine and Health Sciences, UGent , Ghent, Belgium

Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed Close
,
Corin Badiu CI Parhon National Institute of Endocrinology, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Search for other papers by Corin Badiu in
Google Scholar
PubMed Close
, and
Bruno Lapauw Department of Endocrinology, Ghent University Hospital & Department of Internal Medicine & Pediatrics, Faculty of Medicine and Health Sciences, UGent , Ghent, Belgium

Search for other papers by Bruno Lapauw in
Google Scholar
PubMed Close

included the most frequently mutated genes in PPGL: RET, VHL, NF1, MAX, SDHA, SDHB, SDHC, SDHD, SDHAF2, and TMEM127 . Depending on phenotypic features and/or year of diagnosis, patients were tested for a variable number of these genes. For patients with

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-22-0040
Volume/Issue:
Volume 3: Issue 1
Open access
Patrick W Owens Discipline of Surgery, Lambe Institute for Translational Research, School of Medicine, National University of Ireland, Galway, Ireland

Search for other papers by Patrick W Owens in
Google Scholar
PubMed Close
,
Terri Patricia McVeigh Cancer Genetics Unit Royal Marsden NHS Foundation Trust, London, England

Search for other papers by Terri Patricia McVeigh in
Google Scholar
PubMed Close
,
Nicola Miller Discipline of Surgery, Lambe Institute for Translational Research, School of Medicine, National University of Ireland, Galway, Ireland

Search for other papers by Nicola Miller in
Google Scholar
PubMed Close
,
Carole Guerin Department of Endocrine Surgery Centre hospitalo-universitaire de La Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France

Search for other papers by Carole Guerin in
Google Scholar
PubMed Close
,
Frederic Sebag Department of Endocrine Surgery Centre hospitalo-universitaire de La Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France

Search for other papers by Frederic Sebag in
Google Scholar
PubMed Close
,
Denis Quill Discipline of Surgery, Lambe Institute for Translational Research, School of Medicine, National University of Ireland, Galway, Ireland

Search for other papers by Denis Quill in
Google Scholar
PubMed Close
,
Marcia Bell Department of Endocrinology, School of Medicine, National University of Ireland, Galway, Ireland

Search for other papers by Marcia Bell in
Google Scholar
PubMed Close
,
Michael J Kerin Discipline of Surgery, Lambe Institute for Translational Research, School of Medicine, National University of Ireland, Galway, Ireland

Search for other papers by Michael J Kerin in
Google Scholar
PubMed Close
, and
Aoife J Lowery Discipline of Surgery, Lambe Institute for Translational Research, School of Medicine, National University of Ireland, Galway, Ireland

Search for other papers by Aoife J Lowery in
Google Scholar
PubMed Close

factors - the highest among all cancers studied ( Czene et al. 2002 ). Medullary thyroid cancer development is associated with point mutations in the RET proto-oncogene on chromosome 10, of which approximately 25% are germline mutations ( Accardo et al

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-21-0003
Volume/Issue:
Volume 1: Issue 1
Open access
Sylvia L Asa Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA

Search for other papers by Sylvia L Asa in
Google Scholar
PubMed Close
and
Shereen Ezzat Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Shereen Ezzat in
Google Scholar
PubMed Close

functionally important indirectly in sporadic tumors; the MEN2 syndrome associated RET proto-oncogene was shown to be involved in an apoptosis-dependent manner in AIP-deficient somatotroph tumors ( Garcia-Rendueles et al. 2021 ). However, PitNETs generally

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0041
Volume/Issue:
Volume 2: Issue 1
Open access
Catherine M Skefos The University of Texas MD Anderson Cancer Center, Clinical Cancer Genetics Program, Houston, Texas, USA

Search for other papers by Catherine M Skefos in
Google Scholar
PubMed Close
,
Pamela L Brock The Ohio State University College of Medicine, Division of Human Genetics, Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Pamela L Brock in
Google Scholar
PubMed Close
,
Erica Blouch Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Search for other papers by Erica Blouch in
Google Scholar
PubMed Close
, and
Samantha E Greenberg Department of Health Care Sciences, UT Southwestern Medical Center, Dallas, Texas, USA

Search for other papers by Samantha E Greenberg in
Google Scholar
PubMed Close

. PVs in RET, FH, VHL, NF1 , and other genes are also known to increase the risk of PGL and/or PCC. Although individuals with hereditary PPGL syndrome may develop any SDHx - related tumors, the penetrance and phenotype of hereditary PPGL syndrome

Article Type:
Commentary
DOI:
https://doi.org/10.1530/EO-23-0043
Volume/Issue:
Volume 4: Issue 1
Open access